Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model

Yamamoto, S; Sato, I; Fujii, M; Kakimoto, M; Honma, K; Kirihara, S; Nakayama, H; Fukuoka, T; Tamura, S; Ueda, M; Hirohata, S; Watanabe, S

Watanabe, S (通讯作者),Okayama Univ, Fac Hlth Sci, 2-5-1 Shikata Cho,Kita Ku, Okayama, Okayama 7008558, Japan.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2023; 101 (9): 455

Abstract

The liver X receptor (LXR) can enhance cholesterol transporters, which could remove excess cholesterol from foam cells in atheromas. LXR has two subty......

Full Text Link